Search results for: microsatellite instability

Refine your Search
Apply several filters to get precise search results
Showing opportunity 1 - 10 of 14
  • 6550--Microsatellite Instability Equipment

    Type : Bid Notification

    Due : 29 Aug, 2022 (20 months ago)
    Posted : 20 months ago
    Started : 24 Aug, 2022 (20 months ago)

    ****View attachments for full details****

    From: Federal Government (Federal)

  • 6640--Microsatellite Instability Reagents (MSI)

    Type : Bid Notification

    Due : 30 Jan, 2024 (3 months ago)
    Posted : 3 months ago
    Started : 26 Jan, 2024 (3 months ago)

    Please see attachment for solicitation amendment details.

    From: Federal Government (Federal)

  • Automated System for Molecular Testing

    Type : Bid Notification

    Due : 17 Apr, 2020 (about 4 years ago)
    Posted : about 4 years ago
    Started : 13 Apr, 2020 (about 4 years ago)

    In need of an automated system for molecular testing of solid tumors including colorectal cancer, lung cancer, and melanoma to deliver diagnostic and treatment services to our veterans in a timely manner. To facilitate that objective, a system capable of detecting actionable mutations in genes including BRAF, KRAS, NRAS, and EGFR and Microsatellite Instability (MSI) is required.

    From: Federal Government (Federal)

  • for ABI 3500XL genetic analyzer .

    Type : Award

    Due : 07 Mar, 2019 (about 5 years ago)
    Posted : about 6 years ago
    Started : 07 Mar, 2018 (about 6 years ago)

    The instrument will perform the following testing for patients at University of Illinois Hospital: Microsatellite Instability Testing, Bone Marrow Engraftment analysis, KRAS mutation assay, BRAF V600E mutation, EGFR Mutation, B and T cell clonality, HIV genotyping drug resistance, and others.

    From: University of Illinois System (Higher Education)

  • Q301--Anatomic Pathology

    Type : Bid Notification

    Due : 22 Aug, 2023 (8 months ago)
    Posted : 9 months ago
    Started : 07 Aug, 2023 (9 months ago)

    , Leukemic Blood 88237; 88264 26 c-KIT Mutation, Liquid Tumor 81272 6 Colorectal Cancer 7 88342; 88341 x3 17 Consult EGL Slides 88323 2 EGFR FISH 88271 (x2) 88274 2 EGFR Mutation Analysis, NSCLC 81235 6 EGFR Mutations 81235;88381 30 Factor II, DNA Analysis #N/A 1 Factor V Leiden Mutation #N/A 1 FISH analyze 100-300 cells additonal probes 88275 347 FISH analyze 100-300 cells 1 88275 21 FISH DNA Probe additional probe 88271 116 Flow Comprehensive Screening

    From: Federal Government (Federal)

  • Q301--NPOP Tumor Molecular Testing Industry Day

    Type : Bid Notification

    Due : 27 Oct, 2022 (18 months ago)
    Posted : 19 months ago
    Started : 12 Oct, 2022 (19 months ago)

    Testing methodology Ability to detect cancer relevant biomarkers across tumor types. This includes gene alterations, tumor mutation burden, microsatellite instability, loss of heterozygosity (LOH), homologous recombination deficiency (HRD).

    From: Federal Government (Federal)

  • Q301--Anatomic Pathology

    Type : Bid Notification

    Due : 18 Sep, 2023 (7 months ago)
    Posted : 7 months ago
    Started : 12 Sep, 2023 (7 months ago)

    26 c-KIT Mutation, Liquid Tumor 81272 6 Colorectal Cancer 7 88342; 88341 x3 17 Consult EGL Slides 88323 2 EGFR FISH 88271 (x2) 88274 2 EGFR Mutation Analysis, NSCLC 81235 6 EGFR Mutations 81235;88381 30 Factor II, DNA Analysis #N/A 1 Factor V Leiden Mutation #N/A 1 FISH analyze 100-300 cells additional probes 88275 347 FISH analyze 100-300 cells 1 88275 21 FISH DNA Probe additional probe 88271 116 Flow Comprehensive Screening 88184; 88185x23; 88189

    From: Federal Government (Federal)